Having stable access to nutritious food sets children up for better mental and physical health into adulthood.

Pfizer said it would buy a clinical stage biopharma company for up to $7 billion, as it eyes the lucrative weight-loss drug market currently dominated by Eli Lilly and Novo Nordisk. Novo Nordisk Stock ...

US drugmaker Pfizer said Thursday that it has completed its acquisition of biotech firm Metsera, closing a deal worth up to ...

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S.

The question now is how to best serve the millions who, freed from a lifetime of yo-yo dieting, are re-engaging with their ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh.

The US FDA is removing serious health warnings from hormone replacement therapies. Scientists worry that more work is needed ...

Human brains are wired to hold on to fat, resist calorie restriction, and push themselves towards foods that keep them alive, even if they make them gain weight in modern life ...

What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets Just as U.S. households ...

As we found in our recent research, our brains also have powerful mechanisms for defending body weight – and can sort of ...

(Reuters) -U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo ...